Novavax

The UK-based pharmaceutical titan insisted its decision today was a commercial one due to demand being slim, with its jab no longer being manufactured.

Under a huge shake-up to the scheme, from April 1  the high street chain will sell single-dose Pfizer vaccines at 52 stores in England, at an eye-watering cost of £98.95.

A Victoria Police officer who was fired for refusing to get a Covid vaccination has been permanently banned from rejoining the force, despite being 800 police short.

Today the UK's medicines regulator gave the green light to Pfizer's mRNA Omicron jab being sold on the high street. Pfizer has not yet revealed how much it will charge per dose.

Throughout the pandemic, jabs have only been available on the NHS. But under a huge shake-up to the scheme, high street pharmacies will be allowed to sell them by April 1 at the latest.

In fresh guidance issued today, the health agency said that all Americans aged six months and up should get the new updated booster shot this fall.

Weeks after new shots were approved in the US and the vaccine rollout was handed off to private companies, just four million Americans, or one percent, have been inoculated with the latest version.

President Biden has said he will recommend that all Americans roll up their sleeves for an updated Covid booster vaccine this fall.

The Government announced last week that 12.5 million doses of J&J shots would be discarded after the stock expired on May 7, making the vaccine no longer available in the US.

The Food and Drug Administration has authorized Novavax's booster shots which were designed to fight the wild type Covid strain. Anyone 12 and older will be eligible.

An Adelaide woman successfully sued her former company after they sacked her over their vaccine policy while she was waiting for the Novavax jab to become available.

The Novavax 'protein jab', which contains part of the coronavirus spike protein, has been provisionally approved for teenagers aged between 12 and 17.

The BA.5 COVID-19 variant now makes up nearly four of every five infections in the U.S., the CDC revealed Tuesday.

Covid stockpile of Covid vaccines could be headed for the bin, with less than a quarter of the jabs ordered actually administered to Australians.

The Europen companies GSK and Sanofi have partnered for a COVID-19 vaccine candidate that is 72% effective at preventing infection from the Omicron variant.

Novavax'sCovid vaccine received a unanimous recommendation for adults aged 18 years and older from a panel of independent experts at the Food and Drug Administration.

Daily COVID-19 infections have reached the 120,000 mark for the first time since mid-February, but deaths are much lower now than they were then.

The FDA's lead vaccine advisory panel, VRBPAC, will meet this week to discuss approval for the Novavax COVID-19 vaccine.

The Australian Technical Advisory Group on Immunisation recommended Novavax be used as a booster for those 18 and over where an mRNA vaccine such as Pfizer is not suitable.

Novavax, the jab popular with anti-vaxxers, has been approved for use as a booster in Australia by ATAGI - with more than 25,000 doses already being administered.

The Novavax vaccine may finally be available to Americans soon, and one top vaccine expert believes it can help solve some issues health officials have faced during the vaccine rollout so far.

Unvaccinated Australians can now book their first and second doses of Novavax at general practices, community pharmacies and state clinics across the country.

Aussies can now make a booking to get the Novavax Covid vaccine. The health minister hopes it will give the unvaccinated an extra push to get the jab. Here's how it's different to the rest

The vaccine is expected to be popular among those who are not yet double jabbed because it's the first traditional protein-based vaccine to be made available in Australia.

Novavax has officially applied for emergency use authorization for its long awaited Covid shot, the first 'protein based' jab for the virus. The company has faced repeated delays in producing the shot.

On February 21, the vaccine that might persuade some anti-vaxxers to get jabbed will be available in Australia.

The Novavax vaccine is expected to be popular among those who are not yet double jabbed as it is the first protein-based vaccine, with 51 million doses due to arrive in Australia in coming weeks.

The TGA has given the green light to Novavax - the first protein COVID-19 vaccine approved in Australia.

Health minister Karl Lauterbach, who has thrown his support behind a vaccine mandate, has ordered 80million doses of a Biontech vaccine which targets Omicron and should arrive by May.

Federal health minister Greg Hunt has criticised NSW state run clinics, saying they need to 'step up' the level of vaccine shots they are administering.

A first dose of AstraZeneca followed by a second dose of Moderna or Novavax induces more antibodies and T-cells than two AstraZeneca injections, Oxford University researchers found.

The UK Government already has 60million doses of Novavax. It was shown in trials to cause less side effects compared to those triggered by Pfizer, Moderna or even AstraZeneca's vaccines.

Novavax plans to finally submit clinical trial data for its COVID-19 vaccine to FDA regulators by the end of the year, seeking emergency use authorization for its shot.

Novavax, which is based in Gaithersburg, Maryland, said it expects a 'positive decision' from the Medicines and Healthcare products Regulatory Agency (MHRA).

The UK Government announced today that nearly 20,000 participants in the Novavax and Valneva studies will start to be invited from next week.

Almost 20,000 Brits have been effectively banned from travelling to Europe for work, holidays or to see friends and family as they took part in trials for Novavax and Valneva jabs

Vaccine developer Novavax will start a trial on 640 healthy Australia adults, testing their new combination flue and Covid-19 vaccine, which is said to be able to combat new Covid variants.

Boris Johnson had announced that certificates proving double vaccinations will be needed to enter nightclubs and potentially other venues and universities from September.

Those opening up the Covid section of the NHS App can now go through to the 'get your NHS Covid Pass' - which presents two options of 'domestic' or 'travel'.

Dame Kate Bingham took part in early vaccine trials for Novavax but the jab but it is not approved by the Medicines and Healthcare products Regulatory Agency and so is not recognised by the NHS

Novavax was due to seek regulatory authorisation for the shot in the US, Britain and Europe by the end of June, but pushed this back to September - and doesn't even have a date for Australia.

Experts say mixing jabs is unlikely to pose any safety concerns, and that it could even lead to shots being more effective at preventing an infection with the virus.

The Prime Minister told tonight's Downing Street press conference: 'I'm delighted by GSK's investment, which shows the strength of UK manufacturing, and will further boost our rollout.

The Health Secretary last night confirmed the UK has 60 million doses of the Novavax jab on order ahead of its approval by the medicines regulator.

Novavax has enrolled 30,000 participants to its trials in the US and Mexico. The shot was 89.3% effective in UK trials, and works nearly as well against the variant that is dominant there.

'We should be at full capacity starting in May or June, maybe as much as one hundred and 50 million doses per month globally,' said Novavax CEO Stanley Erck on Friday.

Professor Paul Heath said he was confident they would reach 100 infections in two weeks, which would be enough to submit the results to regulators. The jab could be available from the summer.

Kate Bingham, who stepped down as chairwoman of the UK Vaccine Taskforce on January 1, also revealed that she was one of the people who took part in the Novavax trial.

Novavax chief executive Stanley Erck and three of his colleagues offloaded the stock in a series of transactions since the start of 2020, capitalising on a near-3,000 per cent rise in the share price.

Novavax lags behind competitors like Pfizer and Mdoerna, but if its shot succeeds in US trials, its easier transport at refrigerator temperatures - rather than freezers - will help speed vaccination.

Novovax delayed the start of its late-stage US trials for the second time after initially declaring a start date in October and then November due to problems scaling up its manufacturing.

Novavax told The Mail on Sunday that its vaccine 'prevented infection' between rhesus macaque monkeys in testing.

Early results from a clinical trial by Maryland-based company Novavax said two doses of its vaccine produced higher levels of coronavirus antibodies than those seen in recovered patients.

Novavax has received the largest US government award for developing a coronavirus vaccine to-date. The $1.6 billion award is to fund the production of 100 million doses by early 2021.

The US biotech company, which enrolled its first participants in Australia on Monday, said it expected preliminary data on safety and indicators of an immune response from the trial in July.